Can a biological graft improve dialysis access?
NCT ID NCT07773051
First seen Aug 19, 2026 · Last updated Aug 19, 2026
Summary
This trial is testing whether a new biological vascular graft, called LineMatrix, is as safe and effective as a standard graft for creating dialysis access in people with end-stage kidney disease. Participants will be randomly assigned to receive either the new graft or the standard one. The study will track how well the grafts stay open and function over 12 months, aiming to see if the new option can offer a reliable alternative for those who cannot use their own blood vessels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LineMatrix® Biological Vascular Graft
- What this could lead to
- If successful, this could provide a safer, more effective option for creating dialysis access in people with kidney failure who cannot use their own blood vessels.
- What could go wrong
- This is an early-stage trial, and the new graft may not perform as well as the standard one. There are also risks of clotting or infection, as with any vascular access procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS GRAFT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Haidian Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Longhua Hospital Shanghai University of Traditional Chinese Medicine
RECRUITINGShanghai, Shanghai Municipality, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
-
South China Hospital of Shenzhen University
RECRUITINGShenzhen, Guangdong, China
-
The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
RECRUITINGHangzhou, Zhejiang, China
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi’an, Shanxi, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
-
The First Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
-
The Second Affiliated Hospital of Nanjing Medical University
RECRUITINGNanjing, Jiangsu, China
-
Tongji Hospital Affiliated to Tongji Medical Collage of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lab-Grown vessels could revolutionize dialysis access
- Could listening to music make dialysis less painful?
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs